AbbVie hikes full-year earnings guidance as Humira sales top estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. CHYM
3. BRZE
4. USO
5. KFY
6. EVMN
7. NOVN:SW
8. USB
9. DYN
10. NVS

Go back to AbbVie hikes full-year earnings guidance as Humira sales top estimates
AbbVie (NYSE: ABBV) Delayed: 248.78 --0 (-0%)
Previous Close $248.78    52 Week High $68.12 
Open $248.78    52 Week Low $50.71 
Day High $248.78    P/E 53.97 
Day Low $248.78    EPS $4.61 
Volume 1,001